Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | TT-4 |
| Trade Name | |
| Synonyms | TT4|TT 4|PORT7|PORT-7|PORT 7 |
| Drug Descriptions |
TT-4 acts as an antagonist to the adenosine receptor A2BR, which potentially inhibits tumor growth and induces antitumor immune response (Cancer Res (2022) 82 (12_Supplement): 3454). |
| DrugClasses | Adenosine Targeting 25 |
| CAS Registry Number | NA |
| NCIT ID | C181756 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| TT-10 + TT-4 | TT-10 TT-4 | 0 | 1 |
| TT-4 | TT-4 | 0 | 1 |